| Patents for C12P 21 - Preparation of peptides or proteins (112,499) |
|---|
| 06/07/2006 | EP1664115A2 Antibody cdr polypeptide sequences with restricted diversity |
| 06/07/2006 | EP1664114A1 Method for producing a polypeptide |
| 06/07/2006 | EP1664081A2 Novel proteins and nucleic acids encoding same |
| 06/07/2006 | EP1663278A2 Epo mimetic peptides and fusion proteins |
| 06/07/2006 | EP1663110A2 Uses of interferons with altered spatial structure |
| 06/07/2006 | EP1565564A4 Modified antibodies stably produced in milk and methods of producing same |
| 06/07/2006 | EP1501942A4 Methods to identify evolutionarily significant changes in polynucleotide and polypeptide sequences in domesticated plants and animals |
| 06/07/2006 | EP1409673B1 Human leucine-rich repeat containing protein, expressed predominantely in small intestine, hlrrsi1 |
| 06/07/2006 | EP1364023B1 Gene highly expressed in cartilage tissues |
| 06/07/2006 | EP1334183B1 NOVEL SOLUBLE ENDOPROTEASES FOR THE i IN VITRO /i PROCESSING OF RECOMBINANT PROTEINS |
| 06/07/2006 | EP1320552B8 Method for producing human anti-thymocyte immunoglobulins |
| 06/07/2006 | EP1254234B1 Haemophilus influenza outer membrane protein and use thereof in vaccination |
| 06/07/2006 | EP1254216B1 Improved galactosylation of recombinant glycoproteins |
| 06/07/2006 | EP1051620B1 Variable heavy chain and variable light chain regions of antibodies to human platelet glycoprotein ib alpha |
| 06/07/2006 | EP1002081B1 Delayed progression to aids by a missense allele of the ccr2 gene |
| 06/07/2006 | EP0939767B1 Porcine factor viii and hybrids thereof |
| 06/07/2006 | EP0797675B1 Reversible nuclear genetic system for male sterility in transgenic plants |
| 06/07/2006 | EP0772437B1 Compositions for delivery of genetic material |
| 06/07/2006 | CN1784426A Antibody targeted at antigen specific to cancer |
| 06/07/2006 | CN1782091A Method for producing angiotonin converzyme inhibiting peptide by whey proteinase method |
| 06/07/2006 | CN1782076A Method for expressing human bone morphogenetic protein and its special expression vector |
| 06/07/2006 | CN1782073A High efficiency expression of smell molecule combined protein of migratory locust in pronucleus system |
| 06/07/2006 | CN1781947A Modified peptides as therapeutic agents |
| 06/07/2006 | CN1781946A Modified peptides as therapeutic agents |
| 06/07/2006 | CN1781945A Modified peptides as therapeutic agents |
| 06/07/2006 | CN1781936A B lymphocyte stimulus factor inhibiting peptide and its screening and preparing method |
| 06/07/2006 | CN1258539C Compositions and methods for generating monoclonal antibodies representative of a specific cell type |
| 06/07/2006 | CN1258379C Botulinum toxin pharmaceutical composition |
| 06/06/2006 | US7058515 Methods for making character strings, polynucleotides and polypeptides having desired characteristics |
| 06/06/2006 | US7057088 Genetic engineered transgenic plant; controlling,germination |
| 06/06/2006 | US7057028 14273 Receptor, a novel G-protein coupled receptor |
| 06/06/2006 | US7057022 Antibodies which specifically bind to TNF-R |
| 06/06/2006 | US7057016 Process for the production of biologically active protein |
| 06/06/2006 | US7056885 Fibroblast growth factor and nucleic acids encoding same |
| 06/06/2006 | US7056740 Preparing preferential amino acid sequences in vitro; detecting restriction fragment length polymorphisms |
| 06/06/2006 | US7056735 Mimetics and inhibitors of the interaction between Vpr (HIV viral protein of regulation) and ANT (Mitochondrial adenine nucleotide translocator) |
| 06/06/2006 | US7056732 Method for enhancing solubility of recombinant protein products in E. coli |
| 06/06/2006 | US7056731 Sulfotransferase SULT2A1 sequence variants |
| 06/06/2006 | US7056721 EGVI endoglucanase and nucleic acids encoding the same |
| 06/06/2006 | US7056720 LLG polypeptides of the triacylglycerol lipase family, and compositions and methods for their use in enzymatic hydrolysis, and protein and gene therapies |
| 06/06/2006 | US7056717 Comprises nucleotide sequences coding enzymatic polypeptides associated with steroid, carotenoids and squalene biosynthesis |
| 06/06/2006 | US7056714 Nucleotide sequences comprising gene coding protein associated with complex, multicomponent enzyme systems for use in biogeneration of synthetic, aromatic, aliphatic and alicyclic aldehydes and alcohols |
| 06/06/2006 | US7056704 RNA interference mediating small RNA molecules |
| 06/06/2006 | US7056702 Immunoglobulin for detecting inflammation and bacterial infections in mammals |
| 06/06/2006 | US7056701 Hormone and albumin fusion protein |
| 06/06/2006 | US7056700 Use of ClyA hemolysin for excretion of proteins |
| 06/06/2006 | US7056695 TNF-α variants |
| 06/06/2006 | US7056694 DNA encoding peripheral-type benzodiazipine receptor associated protein 7 and applications or methods of use |
| 06/06/2006 | US7056691 Assays for identifying α-galactosidases |
| 06/06/2006 | US7056690 Detection of dysplastic or neoplastic cells using anti-MCM2 antibodies |
| 06/06/2006 | US7056685 Receptor ligands and methods of modulating receptors |
| 06/06/2006 | US7056681 For modulating cytokine, interferon, and tumor necrosis factor levels |
| 06/06/2006 | US7056672 insertion of nucleotides into genetic vectors comprising nucleotide sequences, then transfection into host cells, culturing under conditions permitting gene expression and analyzing for labelled polypeptides; genetic engineering |
| 06/06/2006 | US7056658 Epitope sequence for use as tool in diagnostic analysis |
| 06/06/2006 | US7056518 Malarial pre-erythrocytic stage polypeptide molecules |
| 06/06/2006 | US7056516 Comprises nucleotide sequences coding caspase 8 inhibitory protein for use in the treatment of alzheimer's, parkinson's, arthritic, septic, cardiovascular, inflammatory, osteoporotic and ischemic reperfusion injuries/disorders |
| 06/06/2006 | US7056510 Streptococcus pneumoniae SP036 polynucleotides, polypeptides, antigens and vaccines |
| 06/06/2006 | US7056509 Monoclonal antibodies used as antagonists vascular endothelial growth factors (VEGF); angiogenesis inhibitors; antitumor agents |
| 06/06/2006 | US7056508 Receptor-type phosphotyrosine phosphatase-kappa antibodies |
| 06/06/2006 | US7056505 Antibody for use in the diagnosis, prevention and treatment of infections, autoimmune disorders, arthritis, graft rejection and graft-versus-host disease |
| 06/06/2006 | US7056501 used to develop diagnostic assays for the detection of Neospora infections in cattle and other animals |
| 06/06/2006 | CA2386587C Genes and proteins for the biosynthesis of anthramycin |
| 06/06/2006 | CA2318813C Highly efficient controlled expression of exogenous genes in e. coli |
| 06/06/2006 | CA2301044C Antimicrobial peptide and dna construct and expression system thereof |
| 06/06/2006 | CA2120153C Recombinant immunotoxins |
| 06/06/2006 | CA2071214C Method of delivering molecules into eukaryotic cells |
| 06/06/2006 | CA2053288C Expression of human apolipoproteins ai and ai-milano in yeast |
| 06/06/2006 | CA1341506C Factor viii coagulant polypeptides and monoclonal antibodies to them |
| 06/01/2006 | WO2006058300A2 Antibodies and peptide antigens for producing antibodies having a selective binding specificity to bioactive intact parathyroid hormone (pth) 1-84 |
| 06/01/2006 | WO2006057623A1 Runx3 antibodies and method of obtaining the antibodies |
| 06/01/2006 | WO2006057389A1 Novel transcriptional factor phosphorylated by amp protein kinase and gene thereof |
| 06/01/2006 | WO2006057341A1 Industrially useful microorganism |
| 06/01/2006 | WO2006057339A1 Method of producing antibody |
| 06/01/2006 | WO2006056701A1 Method for directing nucleic acids to plastids |
| 06/01/2006 | WO2006056483A1 Production of proteins |
| 06/01/2006 | WO2006056050A1 Production of heterologous proteins in caulobacter |
| 06/01/2006 | WO2006029538A8 Sialyltransferases comprising conserved sequence motifs |
| 06/01/2006 | WO2006026447A9 Production of tnfr-Ig fusion protein |
| 06/01/2006 | WO2005123766A3 Methods of making nanotechnological and macromolecular biomimetic structures |
| 06/01/2006 | WO2005121331A9 Truncated galnact2 polypeptides and nucleic acids |
| 06/01/2006 | WO2005118796A3 Reconstituted histone methyltransferase complex and methods of identifying modulators thereof |
| 06/01/2006 | WO2005117976A3 Method of increasing radiation sensitivity by inhibition of beta one integrin |
| 06/01/2006 | WO2005095582A3 Novel cell culture medium supplements |
| 06/01/2006 | WO2005094356A3 Cngh0011 polynucleotides, polypeptides, antibodies, and compositions, and methods of production and use |
| 06/01/2006 | WO2005012492A8 Human skin equivalents expressing exogenous polypeptides |
| 06/01/2006 | WO2005001025A3 Immunoglobulin chimeric monomer-dimer hybrids |
| 06/01/2006 | WO2003025542A3 Immune response associated proteins |
| 06/01/2006 | US20060116508 Novel 27411, 23413, 22438, 23553, 25278, 26212, NARC SC1, NARC 10A, NARC 1, NARC 12, NARC 13, NARC17, NARC 25, NARC 3, NARC 4, NARC 7, NARC 8, NARC 11, NARC 14A, NARC 15, NARC 16, NARC 19, NARC 20, NARC 26, NARC 27, NARC 28, NARC 30, NARC 5, NARC 6, NARC 9, NARC 10C, NARC 8B, NARC 9, NARC2A, NARC 16B, NARC 1C, NARC 1A, NARC 25, 86604 and 32222 molecules and uses therefor |
| 06/01/2006 | US20060116505 Glucose and/or fructose transporter naglt1 and its gene |
| 06/01/2006 | US20060115896 Diagnostic test for west nile virus |
| 06/01/2006 | US20060115886 decompose a glycoside having soyasapogenol B as an aglycone to produce soyasapogenol B; a polynucleotide encoding such a protein; soyasapogenol B can be obtained independently of the saponin content of, for example, a soybean extract; host is filamentous fungus belonging to genus Trichoderma, aspergillus |
| 06/01/2006 | US20060115877 Hyaluronate synthase gene and uses thereof |
| 06/01/2006 | US20060115876 Antihemophilic factor (FVIII) muteins covalently bound to biocompatabile polyoxyethylene glycol; low-density lipoprotein receptor; pharmacokinetics; chromatography; hemophilia |
| 06/01/2006 | US20060115875 Characterizing hepatitis C viral infection by determining a similarity between a viral sequence of an hypervariable region 1 (HVR1) of the second envelope protein (E2) region of an hepatitis C virus that infected the host and a variable region kappa light chain of an immunoglobulin of the host |
| 06/01/2006 | US20060115874 Enrichment method for variant proteins with altered binding properties |
| 06/01/2006 | US20060115858 Trace amine 1 receptor of the African green monkey |
| 06/01/2006 | US20060115852 proteins or polypeptides comprising amino acid sequences, used for diagnosis and therapy of diseases associated with oncogenes, such as transcription and apoptosis |
| 06/01/2006 | US20060115839 Methods of identifying an agent that modulates an interaction between 53BP1 and histone H3, and uses thereof |
| 06/01/2006 | US20060115837 Crystals and structure of domain III of West Nile Virus envelope protein in association with a Fab fragment of a neutralizing antibody |
| 06/01/2006 | US20060115836 Utilization of FANCC, DAD1, GRIM19 and HADHII genes for the ultimate treatment of psoriasis |